CORC

浏览/检索结果: 共103条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 会议论文
ANNALS OF ONCOLOGY, 2019-04-01
作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Apparent Diffusion Coefficient (ADC) Measured by Diffusion Weighted MRI Was Highly Correlated with Tumor Cell Survival in Non-Small Cell Lung Cancer (NSCLC) Cell Lines Under Stereotactic Body Radiotherapy (SBRT) Regimens 会议论文
MEDICAL PHYSICS, 2018-06-01
作者:  Wang, Y.;  Qing, K.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS stud 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, Q.;  Zhang, H.;  Jiang, L.;  Shi, Y.;  Chen, Y.
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS) 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Zhou, C.;  Wang, M.;  Cheng, Y.;  Chen, Y.;  Zhao, Y.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Significance of Systemic Immune-inflammation Status as a Prognostic Indicator in Resected Non-small Cell Lung Cancer with Pathological N2 Nodal Involvement 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Wang, J.;  Men, Y.;  Kang, J.;  Sun, X.;  Deng, L.
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
Hippocampal-Sparing Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Phase II Clinical Trial 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Dong, X.;  Zhou, Z.;  Liu, X.;  Wang, W.;  Xiao, Z.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Preoperative Clinical Risk Factors in Selecting Patients with Pathological IIIA-N2 Non-Small-Cell Lung Cancer Benefiting from Postoperative Radiation Therapy: A Propensity Score-Matched Analysis 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Deng, L.;  Hui, Z.;  Men, Y.;  Wang, J.;  Wang, W.
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/03
Clinical Outcomes and Prognostic Factors in Limited-Stage Small Cell Lung Cancer Patients Treated with Intensive Modified Radiation Therapy 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Liu, X.;  Zhou, Z.;  Wang, Y.;  Xin, D.;  Chen, D.
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/03
First-line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-mutant Metastatic Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Lu, X.;  Wang, J.;  Wang, C.;  Bi, N.;  Zhou, Z.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Postoperative Radiation Therapy (PORT) May Not Improve Overall Survival (OS) of Patients with pIIIA-N2 Non-Small-Cell Lung Cancer (NSCLC) with Positive Surgical Margins 会议论文
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018-11-01
作者:  Yuan, M.;  Hui, Z.;  Men, Y.;  Kang, J.;  Sun, X.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace